Growth Metrics

Intelligent Bio Solutions (INBS) Revenue (2019 - 2025)

Intelligent Bio Solutions' quarterly Revenue came in at $728867.0 in Q1 2025, down 11.52% year-on-year from $823800.0 in Q1 2024, and up 19.98% quarter-over-quarter from $607494.0 in Q4 2024.

Intelligent Bio Solutions has reported Revenue for 7 years, with the latest figure at $728867.0 in Q1 2025.

  • For the quarter ending Q1 2025, Revenue fell 11.52% year-over-year to $728867.0; the trailing twelve-month figure through Mar 2025 stood at $3.0 million (up 7.26% YoY), and the FY2023 full-year result was $1.3 million, down 19.65% from the prior year.
  • Revenue for Q1 2025 stood at $728867.0, up from $607494.0 in the prior quarter.
  • The five-year high for Revenue was $1.2 million in Q2 2022, with the low at $34290.0 in Q1 2021.
  • Average Revenue over 5 years is $547884.7, with a median of $457058.0 recorded in 2023.
  • Year-over-year, Revenue surged 2136.79% in 2021 and plunged 62.88% in 2023.
  • Tracing INBS's Revenue over 5 years: stood at $177791.0 in 2021, then surged by 100.62% to $356679.0 in 2022, then surged by 114.22% to $764063.0 in 2023, then fell by 20.49% to $607494.0 in 2024, then climbed by 19.98% to $728867.0 in 2025.
  • The last three Revenue figures came in at $728867.0 (Q1 2025), $607494.0 (Q4 2024), and $872287.0 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 11.16 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.02 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.02 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 5.20 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.65 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.57 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.19 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 5.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.59 Bn
10 Intelligent Bio Solutions 13.61 Mn 12.40 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 728,867.00
Dec 31, 2024 607,494.00
Sep 30, 2024 872,287.00
Mar 31, 2024 823,800.00
Dec 31, 2023 764,063.00
Sep 30, 2023 796,094.00
Jun 30, 2023 443,135.00
Mar 31, 2023 457,058.00
Dec 31, 2022 356,679.00
Sep 30, 2022 347,486.00
Jun 30, 2022 1.19 Mn
Mar 31, 2022 192,500.00
Dec 31, 2021 177,791.00
Jun 30, 2021 422,793.00
Mar 31, 2021 34,290.00
Dec 31, 2020 283,037.00
Sep 30, 2020 55,427.00
Jun 30, 2020 69,000.00
Mar 31, 2020 1,533.00
Dec 31, 2019 798.00